As inflation continues to impact daily expenses, finding affordable meal options has become more important for many consumers. Fortunately, fast-food giants like McDonald’s, Burger King, Starbucks, and Dunkin’ offer a range of budget-friendly meals under $5 that don’t skimp on flavor.
At McDonald’s, the classic McChicken sandwich, a staple for years, remains a fan-favorite priced under $5. Burger King offers its Value Menu, which includes items like the Bacon Cheeseburger and crispy fries, all under the $5 mark. Meanwhile, Starbucks offers a few small bakery items paired with a coffee or tea that can be combined for under $5, catering to those on the go. Dunkin’ also provides options like bagels with cream cheese or a donut paired with coffee for an affordable breakfast solution.
These deals allow fast-food enthusiasts to enjoy their favorite treats without stretching their budget. Keep an eye on these menus for additional limited-time offers, which could make your next meal even more wallet-friendly.


Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
Yes, government influences wages – but not just in the way you might think
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High
Toyota Retains Global Auto Sales Crown in 2025 With Record 11.3 Million Vehicles Sold
Can your cat recognise you by scent? New study shows it’s likely
What’s the difference between baking powder and baking soda? It’s subtle, but significant
The American mass exodus to Canada amid Trump 2.0 has yet to materialize
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
Debate over H-1B visas shines spotlight on US tech worker shortages
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 



